...
首页> 外文期刊>OncoTargets and therapy >High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma
【24h】

High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma

机译:葡萄糖调节蛋白78(GRP78)的高表达与食管鳞状细胞癌的转移和预后不良有关

获取原文
           

摘要

Background: Glucose-regulated protein 78 (GRP78) plays an important role in the invasion and metastasis of many human cancers. However, the role of this protein in the progression of invasion and metastasis in esophageal squamous cell carcinoma (ESCC) remains elusive. Patients and methods: Immunohistochemistry and Western blot were performed to analyze GRP78 expression in 92 patients with primary ESCC. The correlation of GRP78 expression with clinicopathological factors was analyzed. In vitro, the expression levels of GRP78 were downregulated by small interfering RNA transfection in TE-1 and CaEs-17 ESCC lines. Cell invasion and migration assays were applied to determine the invasion and migratory abilities of ESCC cells. Results: Compared with GRP78 in adjacent normal esophageal tissues, GRP78 was overexpressed in ESCC tissues. High GRP78 expression was significantly correlated with positive lymph node metastasis ( P =0.035) and advanced tumor stage ( P =0.017). Survival analysis revealed that high GRP78 expression was significantly associated with shorter overall survival ( P =0.037). In multivariate analysis, GRP78 overexpression was identified as an independent prognostic factor for overall survival ( P =0.011). si-GRP78 can significantly decrease the GRP78 expression level and reverse the invasion and migratory abilities of ESCC cells in TE-1 and CaEs-17 cell lines. Conclusion: These findings demonstrated that high expression of GRP78 was associated with disease progression and metastasis in ESCC and might serve as a novel prognostic marker for patients with ESCC.
机译:背景:葡萄糖调节蛋白78(GRP78)在许多人类癌症的侵袭和转移中起着重要作用。但是,该蛋白在食管鳞状细胞癌(ESCC)侵袭和转移过程中的作用仍然难以捉摸。患者和方法:免疫组织化学和蛋白质印迹分析了92例原发性食管鳞癌中GRP78的表达。分析了GRP78表达与临床病理因素的相关性。在体外,通过小干扰RNA转染TE-1和CaEs-17 ESCC细胞系,GRP78的表达水平被下调。应用细胞侵袭和迁移测定来确定ESCC细胞的侵袭和迁移能力。结果:与邻近的正常食管组织中的GRP78相比,ESCP组织中的GRP78过表达。 GRP78高表达与阳性淋巴结转移(P = 0.035)和晚期肿瘤分期(P = 0.017)显着相关。生存分析表明,高GRP78表达与总体生存期缩短显着相关(P = 0.037)。在多变量分析中,GRP78过表达被确定为整体生存的独立预后因素(P = 0.011)。 si-GRP78可以显着降低GRP78的表达水平,并逆转ES-1细胞在TE-1和CaEs-17细胞系中的侵袭和迁移能力。结论:这些发现表明,GRP78的高表达与ESCC的疾病进展和转移有关,并可能作为ESCC患者的新的预后标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号